SensoGenic

Biosensor for Allergen Detection

Health Tech & Life Sciences
Non Active, Jun 2022 ceased to operate
Seed Rehovot, Israel Founded 2018
Last updated 2026-06-18
Total raised
$777K
Last: Grant 2019-04
Stage
Seed
Founded
2018
Headcount
2
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

SensoGenic is developing a consumer biosensor based on its patented molecule-allergen interaction and electronic detection technology. The company aims to provide a comprehensive solution for people suffering from food allergies.

Funding history · 2 rounds · $777K total

2019-04
Grant $57K
2018-03

Q&A

What is SensoGenic's primary business?
SensoGenic is developing a consumer biosensor for allergen detection, based on its patented molecule-allergen interaction and electronic detection technology, aiming to provide a comprehensive solution for people suffering from food allergies.
When was SensoGenic founded?
SensoGenic was founded in January 2018.
What is SensoGenic's current operational status?
SensoGenic is currently inactive, having ceased operations in June 2022.
How much funding has SensoGenic raised in total?
SensoGenic has raised a total of $776,600 USD across its funding rounds.
Who are the co-founders of SensoGenic?
The co-founders of SensoGenic are Oded Shoseyov, who serves on the Advisory Board for Business Strategy, and Alon Yasovsky, who is the Co-founder & CEO.
Which investor participated in SensoGenic's March 2018 funding round?
eHealth Ventures participated in SensoGenic's funding round in March 2018.
What was SensoGenic's last recorded funding event?
SensoGenic received a Grant round in April 2019 from EU Horizon 2020, amounting to $56,600 USD.
What is the employee count for SensoGenic?
SensoGenic has 1-10 employees.

Team · 2

Founder · Co-Founder, Advisory board Business strategy
LinkedIn ↗
Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
SensingBiologicals
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2B2C

Highlights

1 PatentsVerified

Tags

diagnosticsnon-invasivedata-analyticssensorsfood-safety-and-traceabilitybiotechnologydetectionallergyconsumer-electronicsdigital-healthcaremobile-applicationsnutrition-advicedigital-therapeuticschronic-patientspatients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)